Delivery Order SPE2D021DA002-SPE2D326F1158
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, carries firm fixed-price terms and received no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award represents one...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $22,270.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on October 27, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. No set-aside designation was utilized in this competitive procurement. DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) dose vials on November 17, 2025. This firm fixed-price delivery order, which has no set-aside designation, is structured as a one-time purchase with an ultimate completion date of November 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through unrestricted competition. The delivery order...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vial format. This $1,113.42 firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a regional prime...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F1158Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, utilizes firm fixed-price terms and carries no set-aside designation, reflecting the contractor's ability to compete in unrestricted federal procurement. This award represents one of numerous recent delivery orders issued to DMS Pharmaceutical Group under the Defense Logistics Agency's broader pharmaceutical supply framework. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) awarded by the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products to support Department of Defense military healthcare facilities globally. DMS Pharmaceutical Group's IDC carries a ceiling value of $499,999,999 across a 30-month base period with three 30-month option periods extending through December 31, 2036, positioning the company as a critical supplier of branded and generic prescription drugs, biologics, vaccines, and medical consumables for federal military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/17/25 |